The organisation, promoted by Noel Alimentaria, has celebrated the ninth edition of its scholarship programme at an event attended by more than two hundred people at Sala El Torín in Olot, the capital of La…
This week the Fundació Albert Bosch, an initiative of Noel Alimentaria, received two consecutive accolades linked to its work in the fight against childhood cancer: the CaixaBank Wealth Management Philanthropy Award and, a few days…
At Noel, through La Fundació Albert Bosch, we are joining a new charitable initiative that brings together local roots, popular culture and social commitment. The Foundation has launched four puzzles inspired by Olot’s traditional festive…
At Noel, we celebrated the first Commitment Recognition Day, an event created to recognise the dedication, contribution and professional journey of the people who are part of our company. The sessions took place on 29…
At Noel, we are once again showing that solidarity grows when we join forces. Since the beginning of the year, we have organised several Solidarity Sandwiches, an initiative that has raised €6,895 for the Fundació…
This Christmas, the solidarity campaign linked to the Delizias range has once again brought together efforts in support of the Albert Bosch Foundation and childhood cancer research. Thanks to this initiative, at Noel we will…
As part of Alimentaria-Hostelco 2026, which closed a record-breaking edition with 109,600 visitors, the president of FC Barcelona, Joan Laporta, accompanied by Xavi Puig, board member responsible for women’s football; Bojan Krkić, coordinator of the…
This Saturday, March 28, Fontajau will host a solidarity event to promote childhood cancer research during the match between Bàsquet Girona and Real Madrid “The signing we’re missing”, the new campaign by the Albert Bosch…
• On the occasion of International Childhood Cancer Day, the Albert Bosch Foundation launches a social call in an unexpected setting• The action marks the beginning of a fundraising campaign to boost childhood cancer research…
The new unit, to be located at the Vall d’Hebron Campus in Barcelona, will streamline compound screening and enable the selection of the most effective therapy for each patient The investment required to launch the…
